Recent content by Shining

  1. S

    Follicum Has Very Interesting Results From Its Clinical Fas2a Trials

    The top text by google translate: "It's all about a human protein, osteopontin. This protein is considered to be involved in bone tissue growth. Follicum isolated a portion of this protein and partially modified the amino acid sequence, which generated Follicum's drug candidate FOL-005. In...
  2. S

    Follicum Phase I/ii Clinical Data Showed 8% Increase In Hair Growth

    Well, they started out with pre-clinical trials on mice. There it grew a lots of hair. When they then transplanted skin from the face to the mice they saw the opposite effect. Therefore they didn't knew how this peptide would react on humans so they took the safe road and tried it on the leg...
  3. S

    Follicum Phase I/ii Clinical Data Showed 8% Increase In Hair Growth

    Its a protein where they took the most efficient peptide that they discovered by accident when doing other research that stimulates the hair sack. Follicum starts to be a big thing in Sweden now even if the market haven't spotted this company yet, only a few very interesting big investors...
  4. S

    Follicum Has Very Interesting Results From Its Clinical Fas2a Trials

    This is the interesting part. They have seen a clock wise effect. It seems that the same peptide FOL-005 have an optimal dose where the hair is stimulated and on the upper end with the highest dose they say that it had the opposite effect. Minoxidil has an optimal respond effect when applied 14...
  5. S

    Follicum Has Very Interesting Results From Its Clinical Fas2a Trials

    This is what one professor said as a first comment after the presentation above. "Very fascinating both clinical data and data on diabetes" http://www.med.lu.se/intramed/nyhetsarkiv/140310_professor
  6. S

    Follicum Has Very Interesting Results From Its Clinical Fas2a Trials

    Here is also a text that was written a while ago, that is pointing out the exciting angles with Follicums research. http://aktieraketer.se/2016/09/02/follicum/
  7. S

    Follicum Has Very Interesting Results From Its Clinical Fas2a Trials

    Yes its very good news. Patients that uses Minoxidil have a low respons rate, 38 percent. Follicums candidate has 73 percent and the candidate is not even dose optimized. The Phase2a trials was made with injections, a very bad way to reach the cells inside the hair sack. I think this will be a...
  8. S

    Follicum Has Very Interesting Results From Its Clinical Fas2a Trials

    Yes Tracksterderm, they made some remarkable discoveries along the way. Here is the latest presentation in Swedish, maybe you can use subtitles.
  9. S

    Follicum Has Very Interesting Results From Its Clinical Fas2a Trials

    It seems like this forum docent allow links. This is what the CEO said on Follicums pressrelease (you can find it on their website) :p "– It is exciting to see that we can show a good effect despite that we have not yet developed a final formulation nor have finalized the dosage. In published...
  10. S

    Follicum Has Very Interesting Results From Its Clinical Fas2a Trials

    Hi, I have followed the Swedish company Follicum and they have presented a clinical trial where people got their unique peptide tested on the legs. Despite it is much slower growth on the legs, with only 3 applications a week (Rogaine/minoxidil has a optimal frequency of 14) they showed that...
Top